Sitagliptin Market by Dosage Form (Tablets, Combination Drugs), Indication (Type 2 Diabetes Mellitus, Other indications (as approved or off-label uses)), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Homecare Settings), & Region for 2024-2031
Report ID: 345877|No. of Pages: 202
Sitagliptin Market by Dosage Form (Tablets, Combination Drugs), Indication (Type 2 Diabetes Mellitus, Other indications (as approved or off-label uses)), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Homecare Settings), & Region for 2024-2031
Sitagliptin Market Valuation – 2024-2031
Increasing awareness of the benefits of sitagliptin in managing type 2 diabetes is driving the market size of the sitagliptin market. According to the analyst from Verified Market Research, the Sitagliptin Market is estimated to reach a valuation of USD 60.09 Billion over the forecast subjugating around USD 6.66 Billion valued in 2024.
The rapid expansion of the sitagliptin market is primarily driven by the growing prevalence of type 2 diabetes, which is leading to an increased demand for effective diabetes management solutions. It enables the market to grow at a CAGR of 34.90% from 2024 to 2031.
Sitagliptin Market: Definition/ Overview
Sitagliptin is classified as a DPP-4 inhibitor, specifically developed to manage blood sugar levels in adults with type 2 diabetes. It is recognized for its ability to enhance insulin secretion in response to meals while decreasing glucose production in the liver. This medication is commonly prescribed as part of a comprehensive treatment plan that includes diet and exercise to improve glycemic control.
Increasing awareness of the benefits of Sitagliptin is contributing to its widespread adoption in diabetes management. Additionally, growing research and clinical studies are supporting its effectiveness and safety, further bolstering its market presence. The rising prevalence of type 2 diabetes globally is expected to drive demand for sitagliptin, making it an essential component in the arsenal against diabetes-related complications.
What's inside a VMR
industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=345877
What Key Trends are being Observed in the Adoption of Sitagliptin Among Healthcare Providers and Patients?
Increasing preference for personalized medicine is being observed among healthcare providers, resulting in the growing adoption of Sitagliptin for managing type 2 diabetes. The International Diabetes Federation (IDF) reports that approximately 537 million adults (20-79 years) were living with diabetes in 2021. Enhanced patient outcomes have been attributed to its effective mechanism of action, which is designed to improve glycemic control while minimizing side effects.
The demand for combination therapies is being driven by the recognition that many patients require more than one medication to achieve optimal results, leading to an increase in the prescription of sitagliptin alongside other antidiabetic agents. Additionally, rising awareness about the long-term benefits of diabetes management is encouraging patients to seek out Sitagliptin, resulting in higher market penetration and improved patient adherence to treatment regimens.
Which Restraints are Being Faced by the Sitagliptin Market in Terms of Regulatory Challenges and Competitive Pressures?
Regulatory challenges are being faced by the sitagliptin market due to stringent approval processes imposed by health authorities. Lengthy timelines for obtaining regulatory clearance can impede the introduction of new formulations and combinations, which may limit market growth.
Competitive pressures from alternative diabetes medications are also being felt, as many other options are available that offer similar benefits, leading to potential market share erosion for sitagliptin. Furthermore, increasing scrutiny on pharmaceutical pricing is being imposed by governments and healthcare organizations, which can result in price reductions and impact profit margins within the Sitagliptin market.
Category-Wise Acumens
What are the Key Factors Contributing to the Dominance of Tablet Dosage Forms in the Sitagliptin Market?
The dominance of tablet dosage forms in the sitagliptin market is attributed to their convenience and ease of administration. Tablets are preferred by both healthcare providers and patients, as they offer precise dosing and are generally associated with better patient compliance compared to other forms.
Furthermore, the cost-effectiveness of tablet formulations is recognized, as they are often less expensive to produce than combination drugs or injectable alternatives. This preference is reinforced by the availability of various strengths, allowing for tailored treatment regimens that meet individual patient needs. Consequently, a significant share of the sitagliptin market is held by tablet formulations, underscoring their importance in diabetes management.
Which Distribution Channels are Experiencing Rapid Growth in the Sitagliptin Market?
According to VMR analyst, rapid growth in online pharmacies is being witnessed in the Sitagliptin market, driven by increasing consumer preference for convenience and accessibility. The rise of e-commerce platforms has facilitated easier access to medications, allowing patients to order sitagliptin from the comfort of their homes.
Additionally, the ongoing digital transformation in healthcare is promoting telemedicine and remote consultations, which are leading to increased online prescriptions. As a result, online pharmacies are becoming a vital distribution channel, complementing traditional retail and hospital pharmacies. This shift towards online purchasing is expected to contribute significantly to the overall growth of the sitagliptin market, reflecting changing consumer behaviors in the pharmaceutical landscape.
Gain Access into Sitagliptin Market Report Methodology
https://www.verifiedmarketresearch.com/select-licence/?rid=345877
Country/Region-wise Acumens
What Factors are Contributing to the Dominance of the North American Sitagliptin Market?
According to VMR analyst, the dominance of the North American in sitagliptin market is driven by a combination of advanced healthcare infrastructure and high healthcare expenditure. Significant investments in research and development are being made by pharmaceutical companies, leading to innovative treatment options and improved patient outcomes.
The presence of a large patient population with type 2 diabetes is also contributing to market growth, as well as a well-established network of healthcare providers who are increasingly adopting Sitagliptin as a first-line treatment. The CDC estimates that 37.3 million people in the US have diabetes (11.3% of the population), with 90-95% having type 2 diabetes. Furthermore, strong regulatory support and favorable reimbursement policies are being observed, which facilitate patient access to this medication.
Which Trends are Driving the Rapid Growth of the Sitagliptin Market in the Asia Pacific Region?
According to VMR analyst, Asia Pacific is projected to experience rapid growth in the sitagliptin market. This growth is propelled by increasing diabetes prevalence and rising healthcare awareness. Urbanization and lifestyle changes are contributing to higher rates of type 2 diabetes in this region, necessitating effective management solutions such as sitagliptin. Approximately 60% of the global population with diabetes resides in Asia, with many countries in the region experiencing high prevalence rates. Notably, China and India account for nearly half of all cases globally.
Additionally, growing investments in healthcare infrastructure and expansion of distribution channels are being observed, making medications more accessible to patients. The rising number of diabetic patients is being recognized by healthcare providers, leading to an increase in the prescription of Sitagliptin. Consequently, the Asia Pacific region is emerging as a vital market for sitagliptin, with expectations of sustained growth in the coming years.
Competitive Landscape
The Sitagliptin Market’s competitive landscape is characterized by a varied range of companies, including technology developers, plant operators, and service providers, all striving for market share in an increasingly dynamic and growing industry.
Some of the prominent players operating in the sitagliptin market include:
- AstraZeneca plc
- Boehringer Ingelheim GmbH
- Bristol-Myers Squibb Company
- Reddy’s Laboratories Ltd
- Eli Lilly and Company
- Johnson & Johnson
- Lupin Limited
- Merck & Co., Inc.
- Mylan N.V.
- Novartis AG
- Pfizer,
- Sanofi S.A.
- Sun Pharmaceutical Industries Ltd
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceutical Industries Ltd.
Latest Developments
- In July 2022, Glenmark Pharmaceuticals launched Sitagliptin and its Fixed Dose Combinations (FDCs) under the brand name SITAZIT in India, offering affordable options for adults with Type 2 diabetes.
- In September 2023, the Pharmaceuticals & Medical Devices Bureau of India (PMBI) launched new variants of Sitagliptin at affordable prices under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana, making it available at significantly reduced costs compared to branded versions.
Report Scope
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2021-2031 |
| Growth Rate | CAGR of ~34.90% from 2024 to 2031 |
| Base Year for Valuation | 2024 |
| Historical Period | 2021-2023 |
| Forecast Period | 2024-2031 |
| Quantitative Units | Value in USD Billion |
| Report Coverage | Historical and Forecast Revenue Forecast, Historical and Forecast Volume, Growth Factors, Trends, Competitive Landscape, Key Players, Segmentation Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Players | AstraZeneca plc, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Dr. Reddy’s Laboratories Ltd, Eli Lilly and Company, Johnson & Johnson, Lupin Limited, Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd. |
| Customization | Report customization along with purchase available upon request |
Sitagliptin Market, By Category
Dosage Form:
- Tablets
- Combination Drugs
Indication:
- Type 2 Diabetes Mellitus
- Other indications (as approved or off-label uses)
Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
End-User:
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Homecare Settings
Region:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Research Methodology of Verified Market Research:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Frequently Asked Questions
1 INTRODUCTION OF THE GLOBAL SITAGLIPTIN MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Research Timelines
1.4 Assumptions
1.5 Limitations
2 EXECUTIVE SUMMARY
2.1 Ecology mapping
2.2 Market Attractiveness Analysis
2.3 Absolute Market Opportunity
2.4 Geographical Insights
2.5 Future Market Opportunities
2.6 Global Market Split
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Secondary Research
3.3 Primary Research
3.4 Subject Matter Expert Advice
3.5 Quality Check
3.6 Final Review
3.7 Data Triangulation
3.8 Bottom-Up Approach
3.9 Top-Down Approach
3.10 Research Flow
3.11 Data Sources
4 GLOBAL SITAGLIPTIN MARKET OUTLOOK
4.1 Overview
4.2 Market Evolution
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.4 Porters Five Force Model
4.5 Value Chain Analysis
4.6 Pricing Analysis
5 GLOBAL SITAGLIPTIN MARKET, BY TYPE
5.1 Overview
5.2 Injection
5.3 Tablets
6 GLOBAL SITAGLIPTIN MARKET, BY APPLICATION
6.1 Overview
6.2 Diabetes
6.3 Epilepsy
6.4 Others
7 GLOBAL SITAGLIPTIN MARKET, BY GEOGRAPHY
7.1 Overview
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Italy
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Argentina
7.5.3 Rest of Latin America
7.6 Middle East and Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 South Africa
7.6.4 Rest of Middle East and Africa
8 GLOBAL SITAGLIPTIN MARKET COMPETITIVE LANDSCAPE
8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies
8.4 Company Industry Footprint
8.5 Company Regional Footprint
8.6 Ace Matrix
9 COMPANY PROFILES
9.1 Merck & Co., Inc.
9.1.1 Overview
9.1.2 Financial Performance
9.1.3 Product Outlook
9.1.4 Key Developments
9.2 Novartis AG
9.2.1 Overview
9.2.2 Financial Performance
9.2.3 Product Outlook
9.2.4 Key Developments
9.3 Eli Lilly and Company
9.3.1 Overview
9.3.2 Financial Performance
9.3.3 Product Outlook
9.3.4 Key Developments
9.4 AstraZeneca plc
9.4.1 Overview
9.4.2 Financial Performance
9.4.3 Product Outlook
9.4.4 Key Developments
9.5 Takeda Pharmaceutical Company Limited
9.5.1 Overview
9.5.2 Financial Performance
9.5.3 Product Outlook
9.5.4 Key Developments
9.6 Boehringer Ingelheim GmbH
9.6.1 Overview
9.6.2 Financial Performance
9.6.3 Product Outlook
9.6.4 Key Development
9.7 Sanofi S.A.
9.7.1 Overview
9.7.2 Financial Performance
9.7.3 Product Outlook
9.7.4 Key Development
9.8 Johnson & Johnson
9.8.1 Overview
9.8.2 Financial Performance
9.8.3 Product Outlook
9.8.4 Key Development
9.9 Bristol-Myers Squibb Company
9.9.1 Overview
9.9.2 Financial Performance
9.9.3 Product Outlook
9.9.4 Key Development
9.10 Pfizer Inc.
9.10.1 Overview
9.10.2 Financial Performance
9.10.3 Product Outlook
9.10.4 Key Development
9.11 Mylan N.V.
9.11.1 Overview
9.11.2 Financial Performance
9.11.3 Product Outlook
9.11.4 Key Development
9.12 Lupin Limited
9.12.1 Overview
9.12.2 Financial Performance
9.12.3 Product Outlook
9.12.4 Key Development
9.13 Sun Pharmaceutical Industries Ltd..
9.13.1 Overview
9.13.2 Financial Performance
9.13.3 Product Outlook
9.13.4 Key Development
9.14 Teva Pharmaceutical Industries Ltd.
9.14.1 Overview
9.14.2 Financial Performance
9.14.3 Product Outlook
9.14.4 Key Development
9.15 Dr. Reddy’s Laboratories Ltd
9.15.1 Overview
9.15.2 Financial Performance
9.15.3 Product Outlook
9.15.4 Key Development
10 Appendix
10.1 Related Reports
Report Research Methodology
Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.
This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.
We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:
Exploratory data mining
Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.
All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.
For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.
Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.
Data Collection Matrix
| Perspective | Primary Research | Secondary Research |
|---|---|---|
| Supplier side |
|
|
| Demand side |
|
|
Econometrics and data visualization model
Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.
All the research models are customized to the prerequisites shared by the global clients.
The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.
Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.
Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.
Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:
- Market drivers and restraints, along with their current and expected impact
- Raw material scenario and supply v/s price trends
- Regulatory scenario and expected developments
- Current capacity and expected capacity additions up to 2027
We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.
Primary validation
The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.
The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.
Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:
- Established market players
- Raw data suppliers
- Network participants such as distributors
- End consumers
The aims of doing primary research are:
- Verifying the collected data in terms of accuracy and reliability.
- To understand the ongoing market trends and to foresee the future market growth patterns.
Industry Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|---|---|
|
|
